吸烟者和慢阻肺患者小气道上皮ACE-2表达增加及其对COVID-19的启示
该研究探讨吸烟者和慢阻肺患者下呼吸道支气管上皮细胞中ACE-2(SARS-CoV-2入侵受体)的表达情况。原文指出吸烟者和慢阻肺患者气道ACE-2表达增加,可能解释这些亚群中重症COVID-19风险增高,并强调戒烟的重要性。
要点
- 吸烟者和慢阻肺患者小气道上皮ACE-2表达增加。
- ACE-2是SARS-CoV-2的细胞入口受体。
- 该发现可能解释这些人群重症COVID-19风险增高,强调戒烟。
核心结论
- 吸烟者和慢阻肺患者下呼吸道支气管上皮细胞ACE-2表达增加,可能解释其重症COVID-19风险增高。
研究设计与样本
- 原文未报告具体研究设计与样本量。
主要发现
- 吸烟者和慢阻肺患者气道ACE-2表达增加。
- 截至2020年4月18日,全球COVID-19病例2 280 945例,死亡156 354例。
- 大多数重症病例见于>55岁且有显著合并症(如慢阻肺)者。
临床怎么用
- 提示吸烟者和慢阻肺患者可能为重症COVID-19高危人群,应强调戒烟。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Smokers and those with COPD have increased airway expression of ACE-2, which is the entry receptor for the COVID-19 virus. This may explain the increased risk of severe COVID-19 in these subpopulations and highlight the importance of smoking cessation. https://bit.ly/3bC29es The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) a pandemic [1]. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). COVID-19 displays symptoms ranging from mild to severe (pneumonia) that can lead to death in some individuals [2–4]. As of 18 April 2020, there have been 2 280 945 cases of COVID-19 worldwide and 156 354 deaths [5]. SARS-CoV-2 uses the angiotensin-converting enzyme II (ACE-2) as the cellular entry receptor [6]. While the virus can infect individuals of any age, to date, most of the severe cases have been described in those >55 years of age and with significant comorbidities, such as COPD [7]. Here, we determined whether patients with COPD have increased expression of ACE-2 in bronchial epithelial cells in the lower respiratory tract.
引用
- Leung JM, Yang CX, Tam A, et al. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J. 2020. PMID: 32269089. doi:10.1183/13993003.00688-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。